| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc. (VNDA) has 1 insider with recent SEC Form 4 filings, including 0 buys and 14 sells. VNDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.34M | $13.93M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2021 | Mitchell Stephen Ray66 | Director | Sale+OE | 5,000 | $19.42 | $97,122.00 | -35.2% | -14.0% | -50.3% | |
| Jun 14, 2021 | Chrousos Phaedra | Director | Sell | 2,075 | $19.34 | $40,132.16 | -13.8% | -13.6% | -51.1% | |
| Mar 15, 2021 | Jones Aranthan II66 | Chief Corp. Affairs Officer | Sale+OE | 18,000 | $17.72 | $319,010.40 | -16.1% | +8.7% | -36.7% | |
| Mar 8, 2021 | Polymeropoulos Mihael Hristos77 | President And CEO | Sell | 175,000 | $18.00 | $3,150,052.50 | -12.5% | - | - | |
| Mar 5, 2021 | Williams Timothy69 | SVP &General Counsel | Sell | 5,600 | $17.85 | $99,966.00 | -3.0% | - | - | |
| Mar 2, 2021 | Jones Aranthan II66 | Chief Corp. Affairs Officer | Sell | 3,865 | $18.04 | $69,717.26 | -3.8% | - | - | |
| Mar 2, 2021 | Wijkstrom Joakim64 | SVP, Chief Marketing Officer | Sell | 3,888 | $18.45 | $71,728.93 | -4.7% | - | - | |
| Mar 2, 2021 | Moran Kevin Patrick74 | SVP, CFO &Treasurer | Sell | 9,371 | $18.35 | $171,970.64 | -4.3% | - | - | |
| Mar 2, 2021 | Williams Timothy69 | SVP &General Counsel | Sell | 19,530 | $18.58 | $362,850.36 | -9.2% | - | - | |
| Mar 2, 2021 | Polymeropoulos Mihael Hristos77 | President And CEO | Sell | 22,685 | $18.38 | $416,904.88 | -0.8% | - | - |